Quand faut-il remplacer les AVK par les nouveaux anticoagulants ?
| dc.contributor.author | Daubert, Jean Claude | |
| dc.contributor.author | Fournet, Maxime | |
| dc.date.accessioned | 2020-01-19T12:56:50Z | |
| dc.date.available | 2020-01-19T12:56:50Z | |
| dc.date.issued | 2013-09 | |
| dc.description | p.969-975 | en_US |
| dc.identifier.issn | 0035-2640 | |
| dc.identifier.uri | http://repository.usthb.dz//xmlui/handle/123456789/7984 | |
| dc.language.iso | fr | en_US |
| dc.relation.ispartofseries | In : Revue du Praticien, T63, n°7 (Sept. 2013); | |
| dc.subject | Anticoagulants | en_US |
| dc.subject | Antivitamines K | en_US |
| dc.subject | AVK | en_US |
| dc.subject | Pradaxa (Dabigatran) | en_US |
| dc.subject | Xarelto (Rvaroxaban) | en_US |
| dc.subject | Eliquis (Apixaban) | en_US |
| dc.title | Quand faut-il remplacer les AVK par les nouveaux anticoagulants ? | en_US |
| dc.type | Article | en_US |